Outlook Therapeutics, Inc. (OTLK)

Outlook Therapeutics Revenue

Outlook Therapeutics had revenue of $-1.21M in the quarter ending December 31, 2025. This brings the company's revenue in the last twelve months to $205.70K. In the fiscal year ending September 30, 2025, Outlook Therapeutics had annual revenue of $1.41M.

• Revenue (ttm): $205.70K
• Revenue Growth: n/a
• P/S Ratio: 123.33
• Revenue / Employee: $12,100
• Employees: 17
• Market Cap: 25.37M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	1.41M	-	-
Sep 30, 2024	-	-	-
Sep 30, 2023	-	-	-
Sep 30, 2022	-	-	-
Sep 30, 2021	-	-	-
Sep 30, 2020	-	-	-
Sep 30, 2019	8.15M	5.06M	163.84%
Sep 30, 2018	3.09M	-723.96K	-18.99%
Sep 30, 2017	3.81M	831.94K	27.92%
Sep 30, 2016	2.98M	-2.24M	-42.91%
Sep 30, 2015	5.22M	-3.83M	-42.33%
Sep 30, 2014	9.05M	-	-

Data Source: Fiscal.ai Last updated: Feb 17, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 13, 2026

Data Sources Report a data error